
The objective of this study was to evaluate zzso in adult patients treated with high-dose zzso zzso and zzso followed by zzso stem cell zzso We conducted a retrospective analysis of clinical and laboratory data from 131 patients with various zzso who received treatment with escalating doses of zzso zzso and zzso followed by zzso stem cell transplantation as part of a phase zzso therapeutic zzso zzso in zzso zzso were evaluated by measuring peak zzso levels and zzso dysfunction by the lowest recorded serum levels of zzso zzso and zzso at different time periods after administration of zzso zzso and zzso and after zzso stem cell zzso For the entire group of 131 patients, peak zzso levels were zzso zzso zzso but zzso zzso zzso in 37% and levels were zzso zzso zzso in zzso at some time during their hospital zzso At the time of zzso zzso levels were zzso zzso to zzso zzso in zzso of patients and were zzso 3 zzso in zzso Immediately after high-dose therapy, peak zzso levels were significantly higher in patients receiving higher doses of zzso compared to those receiving lower doses zzso zzso zzso and those receiving intermediate doses zzso zzso zzso There was a dramatic decrease in serum zzso zzso and zzso levels immediately after chemotherapy, and they remained significantly decreased throughout the patient's hospital stay, despite massive replacement efforts zzso ranging between zzso zzso and zzso zzso This is the largest adult population study documenting the zzso and severity of zzso acute zzso Renal dysfunction was dose related and zzso in the majority of zzso 

